JP5967751B2 - Precast gel for electrophoresis, production method and use thereof - Google Patents
Precast gel for electrophoresis, production method and use thereof Download PDFInfo
- Publication number
- JP5967751B2 JP5967751B2 JP2011275630A JP2011275630A JP5967751B2 JP 5967751 B2 JP5967751 B2 JP 5967751B2 JP 2011275630 A JP2011275630 A JP 2011275630A JP 2011275630 A JP2011275630 A JP 2011275630A JP 5967751 B2 JP5967751 B2 JP 5967751B2
- Authority
- JP
- Japan
- Prior art keywords
- gel
- electrophoresis
- glycine
- tricine
- hydroxymethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001962 electrophoresis Methods 0.000 title claims description 45
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 239000000499 gel Substances 0.000 claims description 100
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 60
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 claims description 56
- 239000000872 buffer Substances 0.000 claims description 53
- 239000004471 Glycine Substances 0.000 claims description 30
- 108090000623 proteins and genes Proteins 0.000 claims description 29
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 claims description 28
- 239000007997 Tricine buffer Substances 0.000 claims description 28
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 claims description 28
- 102000004169 proteins and genes Human genes 0.000 claims description 28
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 16
- 239000003792 electrolyte Substances 0.000 claims description 16
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 12
- 230000026731 phosphorylation Effects 0.000 claims description 11
- 238000006366 phosphorylation reaction Methods 0.000 claims description 11
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 claims description 10
- 239000007853 buffer solution Substances 0.000 claims description 9
- 239000003431 cross linking reagent Substances 0.000 claims description 7
- 230000004048 modification Effects 0.000 claims description 7
- 238000012986 modification Methods 0.000 claims description 7
- 229910001428 transition metal ion Inorganic materials 0.000 claims description 7
- 238000010494 dissociation reaction Methods 0.000 claims description 6
- 230000005593 dissociations Effects 0.000 claims description 6
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 5
- 239000004473 Threonine Substances 0.000 claims description 5
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 230000000379 polymerizing effect Effects 0.000 claims description 3
- 229920006322 acrylamide copolymer Polymers 0.000 claims description 2
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 claims description 2
- 229940043264 dodecyl sulfate Drugs 0.000 claims description 2
- 238000000926 separation method Methods 0.000 description 25
- 235000018102 proteins Nutrition 0.000 description 23
- 230000005012 migration Effects 0.000 description 15
- 238000013508 migration Methods 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 12
- 102000011632 Caseins Human genes 0.000 description 10
- 108010076119 Caseins Proteins 0.000 description 10
- 235000021249 α-casein Nutrition 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000007983 Tris buffer Substances 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 229920002401 polyacrylamide Polymers 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 239000012146 running buffer Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 4
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium peroxydisulfate Substances [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 4
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 3
- 239000011837 N,N-methylenebisacrylamide Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 3
- 239000003505 polymerization initiator Substances 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- HNUWDURNWORUHQ-UHFFFAOYSA-N 2-amino-5-hydroxy-4,4-bis(hydroxymethyl)pentane-2-sulfonic acid Chemical compound OCC(CC(S(=O)(=O)O)(N)C)(CO)CO HNUWDURNWORUHQ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003623 transition metal compounds Chemical class 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- AJTVSSFTXWNIRG-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanesulfonic acid Chemical compound OCC[NH+](CCO)CCS([O-])(=O)=O AJTVSSFTXWNIRG-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010008488 Glycylglycine Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- VAZSKTXWXKYQJF-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)OOS([O-])=O VAZSKTXWXKYQJF-UHFFFAOYSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- -1 divinyl compound Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940043257 glycylglycine Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- KAKZBPTYRLMSJV-UHFFFAOYSA-N vinyl-ethylene Natural products C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44747—Composition of gel or of carrier mixture
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Description
本発明は生化学医薬分析を目的とする電気泳動用ポリアクリルアミドプレキャストゲル、その使用法及びその製法に関するものである。 The present invention relates to a polyacrylamide precast gel for electrophoresis for biochemical drug analysis, a method for using the same, and a method for producing the same.
電気泳動用ポリアクリルアミドプレキャストゲルは、蛋白質など生体を構成する重要な物質の検出並びに定量分析を目的として、生物学、医学、水産学、獣医学など多くの分野における基礎的研究手段とし広く使用されている。特にポリアクリルアミドゲルは人工的に合成された物質であるため、処方を変えることで分離特性の異なるゲルを容易に作成できる。そのため、予め様々な分離特性を持つように量産されたプレキャストゲルを使用することで分析の手間を大幅に省き、均一で再現性が良いことから当該分野における生産および品質管理に貢献するところが大きい。また、量産されたプレキャストゲルを供給するに際しては、保存安定性が良好であることが期待される。 Polyacrylamide precast gels for electrophoresis are widely used as basic research tools in many fields such as biology, medicine, fisheries, and veterinary medicine for the purpose of detection and quantitative analysis of important substances such as proteins. ing. In particular, since polyacrylamide gel is an artificially synthesized substance, gels with different separation characteristics can be easily prepared by changing the formulation. For this reason, the use of precast gels that are mass-produced to have various separation characteristics in advance greatly reduces the labor of analysis, and contributes to production and quality control in this field because they are uniform and have good reproducibility. In addition, when supplying mass-produced precast gel, it is expected that the storage stability is good.
ライフサイエンス分野の分析対象としては、近年は蛋白質の修飾状態が注目され始めている。蛋白質は、生体内で300種類以上の翻訳後修飾によって機能を付与されており、特に、哺乳類は生体内の3分の1の蛋白質がりん酸化修飾状態にあるといわれ、様々な疾患の発症機構や早期発見、治療につなげるため、蛋白質のりん酸化修飾状態を調べることが行われている。 In recent years, protein modification status has begun to attract attention as an analysis target in the life science field. Proteins are functionalized by more than 300 post-translational modifications in vivo, especially in mammals, where it is said that one third of proteins in the body are in a phosphorylated modified state, and the pathogenesis of various diseases In order to lead to early detection and treatment, the phosphorylation modification state of proteins has been investigated.
ゲル電気泳動法による蛋白質のりん酸化状態の分析方法としてアニオン性基をもつ化合物に対しキレート形成能力を持つ側鎖を導入したアクリルアミドモノマーを共重合したポリアクリルアミドゲルが提案されている。このゲルを用いると、りん酸化修飾状態により移動度が異なり、同一構造の蛋白質でもりん酸化状態により分離することが可能となる。(特許文献1、2) As a method for analyzing the phosphorylation state of a protein by gel electrophoresis, a polyacrylamide gel obtained by copolymerizing an acrylamide monomer into which a side chain having a chelating ability is introduced into a compound having an anionic group has been proposed. When this gel is used, the mobility varies depending on the phosphorylation modification state, and even proteins having the same structure can be separated by the phosphorylation state. (Patent Documents 1 and 2)
従来、ポリアクリルアミドゲル電気泳動法には、レムリーによって提案された緩衝液の組み合わせが広く使用され、一般的な方法となっている。レムリーの方法はゲル緩衝液としてトリス(ヒドロキシメチル)アミノメタン(以下トリスと略す)の塩酸による部分中和物を使用し、泳動緩衝液にはトリス、グリシンを使用している(レムリーの泳動緩衝液)。この方法におけるゲル緩衝液は、pHが8.8になるようにトリスが塩酸により部分中和されている(レムリーのゲル緩衝液)。(非特許文献1) Conventionally, the combination of buffer solutions proposed by Remley has been widely used for polyacrylamide gel electrophoresis, and has become a common method. The Remley method uses a partially neutralized product of tris (hydroxymethyl) aminomethane (hereinafter abbreviated as “Tris”) with hydrochloric acid as the gel buffer, and Tris and glycine as the electrophoresis buffer (Lemley's electrophoresis buffer). liquid). In the gel buffer in this method, Tris is partially neutralized with hydrochloric acid so as to have a pH of 8.8 (Lemley gel buffer). (Non-Patent Document 1)
特に、低分子量の蛋白質に対しては、特にシャガーらが提案した泳動緩衝液にトリス、トリシン使用した方法が広く利用されている。この方法におけるゲル緩衝液は、pHが8.45になるようにトリスが塩酸により中和されている。(非特許文献2) In particular, for low molecular weight proteins, a method using Tris or Tricine in an electrophoresis buffer proposed by Shagar et al. Is widely used. In the gel buffer solution in this method, Tris is neutralized with hydrochloric acid so that the pH is 8.45. (Non-Patent Document 2)
前記特許文献1においても、レムリーの方法を用いた例が実施例として提案されている。 Also in Patent Document 1, an example using the Remley method is proposed as an example.
しかしレムリーあるいはシャガーらのゲル緩衝液のpHでは、アミド基は経時的に加水分解反応を受け、蛋白質の泳動距離が短くなると共に分離像は不鮮明となるのでゲルを長期に保存することはできなかった。予め量産したゲルを供給するプレキャストゲルにおいては保管期限を限定して供給する必要があり保存安定性が良好であることが必要とされる。 However, at the pH of the gel buffer of Remley or Shagar et al., The amide group undergoes a hydrolysis reaction over time, the migration distance of the protein becomes shorter and the separation image becomes unclear, so the gel cannot be stored for a long time. It was. A precast gel that supplies a mass-produced gel in advance needs to be supplied with a limited shelf life, and it is required that the storage stability is good.
本出願人においても特許文献3及び特許文献4、特許文献5に報告されているように、電気泳動用ポリアクリルアミドゲルの品質向上や製造方法、使用方法について鋭意研究を行い、課題を解決してきた経緯がある。 As reported in Patent Document 3, Patent Document 4, and Patent Document 5, the present applicant has also conducted extensive research on quality improvement, production method, and use method of polyacrylamide gel for electrophoresis, and has solved the problem. There is a background.
本発明の目的は、蛋白質の分離能及びゲルの形状が長期安定で、分析方法が普及しているレムリーあるいはシャガーの泳動緩衝液が使用可能であり、使用者が経済的かつ効率的に分析を遂行することが可能な、蛋白質のりん酸化修飾状態の分析を目的として使用される電気泳動用プレキャストゲルを提供することにある。 The object of the present invention is to allow the use of Remley or Shagar's running buffer, which has a long-term stable protein separation and gel shape, and is widely used in analysis methods. An object of the present invention is to provide a precast gel for electrophoresis which can be carried out and used for the purpose of analyzing the phosphorylation modification state of a protein.
本発明者らは、前記課題を解決するために鋭意研究を重ねた結果、以下の発明を見出した。
すなわち請求項1の発明は、その構造中の少なくとも一部に下記式(A)で表される構造を有し、下記組成(1)および(2)の緩衝液を含有するアクリルアミド系共重合体水性ゲルであることを特徴とする電気泳動用プレキャストゲルに関する。
(1)トリス(ヒドロキシメチル)アミノメタンおよび/またはビス(2−ヒドロキシエチル)イミノトリス(ヒドロキシメチル)メタンと1種以上の両性電解質として、グリシンおよび/またはトリシン、グリシンおよび/またはトリシン以外の両性電解質としてスレオニンを含有し、グリシンおよび/またはトリシン以外の両性電解質が、グリシンおよび/またはトリシンに対して63.2〜100mol%の範囲で含まれる両性電解質。
(2)pHが6.0〜6.8。
化合物(A)
式中、M2+は遷移金属イオン
As a result of intensive studies to solve the above problems, the present inventors have found the following invention.
That is, the invention of claim 1 has an acrylamide copolymer having a structure represented by the following formula (A) in at least a part of the structure and containing a buffer solution having the following compositions (1) and (2). The present invention relates to a precast gel for electrophoresis, which is an aqueous gel.
(1) Tris (hydroxymethyl) aminomethane and / or bis (2-hydroxyethyl) iminotris (hydroxymethyl) methane and one or more ampholytes as glycine and / or tricine, amphoteric electrolytes other than glycine and / or tricine An amphoteric electrolyte containing threonine as an amphoteric electrolyte other than glycine and / or tricine in an amount of 63.2 to 100 mol% based on glycine and / or tricine.
(2) pH is 6.0-6.8.
Compound (A)
In the formula, M 2+ is a transition metal ion.
請求項2の発明は、1種以上の両性電解質において、グリシンおよび/またはトリシン以外の両性電解質の塩基解離定数の範囲が6.6〜9.6であることを特徴とする請求項1に記載の電気泳動用プレキャストゲル。 A second aspect of the present invention, in one or more ampholytes, according to claim 1, the range of a base dissociation constant of glycine and / or ampholytes than tricine is characterized in that it is a 6.6 to 9.6 Precast gel for electrophoresis.
請求項3の発明は、ゲル中のトリス(ヒドロキシメチル)アミノメタンおよび/またはビス(2−ヒドロキシエチル)イミノトリス(ヒドロキシメチル)メタンの濃度が、0.07〜0.2mol/Lであり、1種以上の両性電解質の濃度の合計が0.1〜0.5mol/Lであることを特徴とする請求項1〜2に記載の電気泳動用プレキャストゲル。 In the invention of claim 3, the concentration of tris (hydroxymethyl) aminomethane and / or bis (2-hydroxyethyl) iminotris (hydroxymethyl) methane in the gel is 0.07 to 0.2 mol / L. The precast gel for electrophoresis according to claim 1 or 2 , wherein the total concentration of the amphoteric electrolytes of the species or more is 0.1 to 0.5 mol / L.
請求項4の発明は、アクリルアミド、下記化合物(B)、架橋剤、トリス(ヒドロキシメチル)アミノメタンおよび/またはビス(2−ヒドロキシエチル)イミノトリス(ヒドロキシメチル)メタン、および1種以上の両性電解質として、グリシンおよび/またはトリシン、グリシンおよび/またはトリシン以外の両性電解質としてスレオニンを含有し、グリシンおよび/またはトリシン以外の両性電解質が、グリシンおよび/またはトリシンに対して63.2〜100mol%の範囲で含まれる両性電解質からなり、pHが6.0〜6.8である混合物水溶液を重合することを特徴とする電気泳動用プレキャストゲルの製造方法。
化合物(B)
式中、M2+は遷移金属イオン
A fourth aspect of the present invention, acrylamide, the following compound (B), a crosslinking agent, a tris (hydroxymethyl) aminomethane and / or bis (2-hydroxyethyl) iminotris (hydroxymethyl) methane, and one or more ampholytes Glycine and / or tricine, threonine as an amphoteric electrolyte other than glycine and / or tricine, and the ampholyte other than glycine and / or tricine is in the range of 63.2 to 100 mol% with respect to glycine and / or tricine. A method for producing a precast gel for electrophoresis, comprising polymerizing a mixed aqueous solution comprising an ampholyte contained therein and having a pH of 6.0 to 6.8.
Compound (B)
In the formula, M 2+ is a transition metal ion.
請求項5の発明は、請求項1〜3に記載の電気泳動用プレキャストゲルと、ドデシル硫酸塩が存在するトリス(ヒドロキシメチル)アミノメタン及び両性電解質を含有する泳動用緩衝液を用い、蛋白質のりん酸化修飾状態を分析することを特徴とする電気泳動用プレキャストゲルの使用方法。
The invention of claim 5 uses a precast gel for electrophoresis according to claims 1 to 3 and a buffer for electrophoresis containing tris (hydroxymethyl) aminomethane in which dodecyl sulfate is present and an amphoteric electrolyte. A method of using a precast gel for electrophoresis, characterized by analyzing a phosphorylated modification state.
本発明により、蛋白質の分離能及びゲルの形状が長期安定で、分析方法が普及しているレムリーあるいはシャガーの泳動緩衝液が使用でき使用者が経済的かつ効率的に分析を遂行することが可能な、蛋白質のりん酸化修飾状態の分析を目的として使用される電気泳動用プレキャストゲルを提供することができる。 According to the present invention, protein separation ability and gel shape are stable for a long period of time, and Remley or Shagar's running buffer, for which analysis methods are widely used, can be used, and the user can perform analysis economically and efficiently. In addition, it is possible to provide a precast gel for electrophoresis used for the purpose of analyzing the phosphorylation modification state of a protein.
本発明の電気泳動用プレキャストゲルには、泳動用分離媒体とゲル緩衝液および分離媒体を保持するための担持体から構成される。また本発明の前記泳動用分離媒体は、アクリルアミド、下記化合物(B)、架橋剤、トリス(ヒドロキシメチル)アミノメタンおよび/またはビス(2−ヒドロキシエチル)イミノトリス(ヒドロキシメチル)メタン、および1種以上の両性電解質からなり、pHが6.0〜6.8である混合物水溶液を重合することにより製造可能である。 The electrophoresis precast gel of the present invention comprises a separation medium for electrophoresis, a gel buffer, and a support for holding the separation medium. The separation medium for electrophoresis of the present invention includes acrylamide, the following compound (B), a crosslinking agent, tris (hydroxymethyl) aminomethane and / or bis (2-hydroxyethyl) iminotris (hydroxymethyl) methane, and one or more kinds. It can be produced by polymerizing an aqueous mixture solution having a pH of 6.0 to 6.8.
化合物(B)
式中、M2+は遷移金属イオン
Compound (B)
In the formula, M 2+ is a transition metal ion.
前記化合物(B)はアクリルアミドに対し、0.003〜0.3質量%の範囲で共重合させることが望ましい。0.3質量%よりも多いと重合度が十分に大きくならず泳動用媒体としての使用に適さず、0.003質量%以下では目的とするりん酸化状態による分離効果が得られない。 The compound (B) is desirably copolymerized in the range of 0.003 to 0.3% by mass with respect to acrylamide. If the amount is more than 0.3% by mass, the degree of polymerization is not sufficiently increased and is not suitable for use as a migration medium, and if it is 0.003% by mass or less, the desired separation effect due to the phosphorylated state cannot be obtained.
前記化合物(B)の遷移金属イオンとしては、鉄、マンガン、銅、亜鉛などの二価イオンが望ましく、特に好ましくは2価亜鉛イオンである。化合物(B)は遷移金属イオンが配位した状態でアクリルアミドと混合しても良いし、重合時に二価の遷移金属化合物を添加して共重合体中に配位構造を形成しても良い。遷移金属化合物としては、塩化亜鉛、酢酸亜鉛、硫酸亜鉛などを用いることができる。 The transition metal ion of the compound (B) is preferably a divalent ion such as iron, manganese, copper, or zinc, and particularly preferably a divalent zinc ion. Compound (B) may be mixed with acrylamide in a state where transition metal ions are coordinated, or a divalent transition metal compound may be added during polymerization to form a coordination structure in the copolymer. As the transition metal compound, zinc chloride, zinc acetate, zinc sulfate or the like can be used.
前記架橋剤としては、N,N−メチレンビスアクリルアミド、N,N−ジアリル酒石酸アミド等の一般的なジビニル化合物を使用することができる。 As the crosslinking agent, a general divinyl compound such as N, N-methylenebisacrylamide, N, N-diallyl tartaramide, and the like can be used.
前記架橋剤はアクリルアミドと化合物(B)の合計質量に対し、0.5〜7質量%の範囲で共重合させることが望ましい。0.5質量%以下では、ゲルが柔らかくなりすぎて操作が難しく、7質量%以上では鮮明な分離パターンを得ることが出来ない。 The crosslinking agent is preferably copolymerized in the range of 0.5 to 7% by mass with respect to the total mass of acrylamide and the compound (B). If it is 0.5 mass% or less, the gel becomes too soft and difficult to operate, and if it is 7 mass% or more, a clear separation pattern cannot be obtained.
前記アクリルアミドと化合物(B)と架橋剤との合計が3〜25質量%となるように用いることが電気泳動用プレキャストゲルとしての使用に好ましい。 It is preferable for use as a precast gel for electrophoresis that the total of the acrylamide, the compound (B) and the crosslinking agent is 3 to 25% by mass.
前記ゲル緩衝液は、トリス(ヒドロキシメチル)アミノメタンおよび/またはビス(2−ヒドロキシエチル)イミノトリス(ヒドロキシメチル)メタンと1種以上の両性電解質を含有する。 The gel buffer contains tris (hydroxymethyl) aminomethane and / or bis (2-hydroxyethyl) iminotris (hydroxymethyl) methane and one or more ampholytes.
レムリーの泳動緩衝液を用いる場合には上記両性電解質として、グリシンがあげられ、シャガーの泳動緩衝液を用いる場合にはグリシンまたはトリシンのいずれも用いることができる。またグリシンおよび/またはトリシンとそれ以外の両性電解質を組み合わせることで、分画分子量範囲を広げることが可能となる。 Glycine can be used as the ampholyte when using the Remley running buffer, and either glycine or tricine can be used when using the Shagar running buffer. Further, by combining glycine and / or tricine with other ampholytes, it is possible to expand the molecular weight range.
グリシンあるいはトリシン以外の両性電解質は、塩基解離定数の範囲が6.6〜9.6であることが好ましい。具体的に両性電解質としてあげれば、グリシン、トリシン、セリン、スレオニン、フェニルアラニン、グルタミン酸、トリプトファン、メチオニン、アラニン、バリン、アスパラギン酸、
N,N−ビス(2−ヒドロキシエチル)グリシン、トリス(ヒドロキシメチル)メチルアミノプロパンスルホン酸、2−アミノエチルスルホン酸、N,N−ビス(2−ヒドロキシエチル)−2−アミノエタンスルホン酸、3−N−モルホリノプロパンスルホン酸、N−トリス(ヒドロキシメチル)メチル−2−アミノエタンスルホン酸、N−2−ヒドロキシエチルピペラジン−N‘−2−エタンスルホン酸、N−2−ヒドロキシエチルピペラジンプロパンスルホン酸、グリシルグリシン、トリス(ヒドロキシメチル)メチルアミノプロパンスルホン酸、N−トリス(ヒドロキシメチル)メチル−2−アミノエタンスルホン酸、2−アミノエチルスルホン酸などあり、これら両性電解質を二種以上組み合わせて用いることもできる。
The amphoteric electrolyte other than glycine or tricine preferably has a base dissociation constant in the range of 6.6 to 9.6. Specific examples of ampholytes include glycine, tricine, serine, threonine, phenylalanine, glutamic acid, tryptophan, methionine, alanine, valine, aspartic acid,
N, N-bis (2-hydroxyethyl) glycine, tris (hydroxymethyl) methylaminopropanesulfonic acid, 2-aminoethylsulfonic acid, N, N-bis (2-hydroxyethyl) -2-aminoethanesulfonic acid, 3-N-morpholinopropanesulfonic acid, N-tris (hydroxymethyl) methyl-2-aminoethanesulfonic acid, N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, N-2-hydroxyethylpiperazinepropane There are sulfonic acid, glycylglycine, tris (hydroxymethyl) methylaminopropanesulfonic acid, N-tris (hydroxymethyl) methyl-2-aminoethanesulfonic acid, 2-aminoethylsulfonic acid, etc. It can also be used in combination.
これらの両性電解質は、ゲル内の電位勾配を緩やかにして分画分子量範囲を蛋白質の分離に適した範囲とし、分離パターンを鮮明にするために添加される。レムリーあるいはシャガーの泳動緩衝液とpHが6.0〜6.8のゲルを用いて電気泳動を行った場合、両性電解質が未添加のゲルを用いると、泳動速度が早く分画分子量範囲が極端に高分子領域になるか、あるいは泳動速度が遅く分離パターンが不鮮明で分離に適さない結果となる。特に好ましくは、2種以上の両性電解質を組み合わせた場合で、pKbの低いものから順に陽極側へ移動するためグリシンあるいはトリシン単独の場合よりも、ゲル内の電位勾配の変化が緩やかなものとなり分離可能な蛋白質の特に低分子領域で鮮明な分離パターンを得ることができる。 These ampholytes are added to moderate the potential gradient in the gel so that the molecular weight cut-off range is suitable for protein separation and the separation pattern is clear. When electrophoresis is performed using Remley or Shagar's running buffer and a gel with a pH of 6.0 to 6.8, using a gel to which no ampholyte is added, the migration speed is high and the molecular weight range is extremely low. The result is a high molecular region, or the migration speed is slow and the separation pattern is unclear and unsuitable for separation. Particularly preferably, when two or more amphoteric electrolytes are combined, the potential gradient in the gel changes more slowly than the case of glycine or tricine alone, because they move to the anode side in order from the lowest pKb. A clear separation pattern can be obtained in a particularly low-molecular region of possible proteins.
また、共存両性電解質の塩基解離定数pKbがpKb<6.6の場合、共存両性電解質はゲル内で酸解離状態となりゲル緩衝液のpHを変化させ、トレイリングイオンとして作用するために分離パターンに本来ないはずのバンドが検出されることになる。pKb>9.6の場合、グリシンよりも塩基解離定数が高いことになるため、ゲル内の電位勾配の変化を緩やかにする作用に寄与しない。 In addition, when the base dissociation constant pKb of the coexisting ampholyte is pKb <6.6, the coexisting ampholyte becomes in an acid dissociation state in the gel, changes the pH of the gel buffer, and acts as a trailing ion. A band that should not be present is detected. In the case of pKb> 9.6, since the base dissociation constant is higher than that of glycine, it does not contribute to the action of moderately changing the potential gradient in the gel.
ゲル緩衝液中のトリス(ヒドロキシメチル)アミノメタンおよび/またはビス(2−ヒドロキシエチル)イミノトリス(ヒドロキシメチル)メタンの濃度は、0.07mol/L〜0.2mol/L、好ましくは0.08mol/L〜0.1mol/Lである。この範囲は、レムリーのゲル緩衝液を使用して作成したゲルと同等の泳動時間を有するために必要なゲル中のリーディングイオンの量を含有させることのできる範囲である。ゲル中のトリス(ヒドロキシメチル)アミノメタンの濃度が0.07mol/Lよりも低い場合、泳動像全体が不鮮明となり蛋白質の分離分析に使用しがたいものとなる。ゲル中のトリス濃度が0.2mol/Lより高くなるとゲル中のリーディングイオン濃度が高くなり、泳動時間が延長し、分析の作業効率が悪くなる。 The concentration of tris (hydroxymethyl) aminomethane and / or bis (2-hydroxyethyl) iminotris (hydroxymethyl) methane in the gel buffer is 0.07 mol / L to 0.2 mol / L, preferably 0.08 mol / L. L to 0.1 mol / L. This range is a range in which the amount of leading ions in the gel necessary to have a migration time equivalent to that of a gel prepared using the Remley gel buffer can be contained. When the concentration of tris (hydroxymethyl) aminomethane in the gel is lower than 0.07 mol / L, the entire electrophoretic image becomes unclear and becomes unusable for protein separation analysis. When the Tris concentration in the gel is higher than 0.2 mol / L, the leading ion concentration in the gel is increased, the migration time is extended, and the analysis work efficiency is deteriorated.
また、グリシンおよび/またはトリシンと、それらと共存する両性電解質の濃度の合計は0.1〜0.5mol/Lであることが好ましい。特に好ましくは0.1〜0.3mol/Lである。全両性電解質濃度が0.1mol/Lよりも少なければその効果は小さくなり泳動像は不鮮明で使用目的を達成できないし、0.5mol/Lより多くなると、十分な蛋白質のりん酸化状態に対する分離能を得ることができなくなる。 The total concentration of glycine and / or tricine and the amphoteric electrolyte coexisting with them is preferably 0.1 to 0.5 mol / L. Most preferably, it is 0.1-0.3 mol / L. If the total ampholyte concentration is less than 0.1 mol / L, the effect is small, and the electrophoretic image is unclear and the purpose of use cannot be achieved. You will not be able to get.
また、共存両性電解質の添加量はグリシンおよび/またはトリシンに対して0.1〜100mol%が好ましい。0.1mol%より低添加量の場合、ゲル内の電位勾配の変化を緩やかにする作用に寄与せず、100mol%よりも多く添加すると分離パターンは、不鮮明となるか、鮮明でも本来ないはずのバンドが検出される。 The amount of the coexisting amphoteric electrolyte is preferably 0.1 to 100 mol% with respect to glycine and / or tricine. When the addition amount is lower than 0.1 mol%, it does not contribute to the action of gradual change of the potential gradient in the gel, and when it is added more than 100 mol%, the separation pattern becomes unclear or should not be clear but originally A band is detected.
前記ゲル緩衝液のpHは、6.0〜6.8である。pH6.8よりも高い場合、ポリアクリルアミドゲルの加水分解が進行し易くなり、保管有効期限を長く持たせることが出来ない。pH6.0より低い場合
、ポリアクリルアミドゲルとしての安定性は良好であるが、蛋白質の泳動像が不鮮明で実用に耐えないものとなる。pH6.8では冷蔵保存で6ヶ月もち、さらにpH6.3ではアクリルアミド自体のpHに近いため、pH6.8に比べ加水分解速度が著しく減少する。その結果1年もの長期間ゲルの形状、泳動像共に変化は見られず安定である。
The pH of the gel buffer is 6.0 to 6.8. When the pH is higher than 6.8, hydrolysis of the polyacrylamide gel tends to proceed, and the storage expiration date cannot be prolonged. When the pH is lower than 6.0, the stability as a polyacrylamide gel is good, but the electrophoretic image of the protein is unclear and unusable for practical use. At pH 6.8, refrigerated storage lasts for 6 months, and at pH 6.3, the hydrolysis rate is remarkably reduced compared to pH 6.8 because it is close to the pH of acrylamide itself. As a result, the gel shape and electrophoretic image have not been changed for a long period of one year and are stable.
pH調製のためにトリス(ヒドロキシメチル)アミノメタンおよび/またはビス(2−ヒドロキシエチル)イミノトリス(ヒドロキシメチル)メタンは、塩酸または酢酸によって中和される。 For pH adjustment, tris (hydroxymethyl) aminomethane and / or bis (2-hydroxyethyl) iminotris (hydroxymethyl) methane are neutralized with hydrochloric acid or acetic acid.
本発明のプレキャストゲルには、ゲルに弾力性を持たせゲル強度を向上させるため、アガロース、ポリアクリルアミド、ポリビニルアルコール、ポリビニルピロリドン、ポリエチレンオキサイド、ポリメチルビニルエーテル等の水溶性ポリマーを含有させることもできる。 The precast gel of the present invention may contain a water-soluble polymer such as agarose, polyacrylamide, polyvinyl alcohol, polyvinyl pyrrolidone, polyethylene oxide, polymethyl vinyl ether, etc. in order to give the gel elasticity and improve gel strength. .
本発明のプレキャストゲルは、アクリルアミド、前記化合物(B)、架橋剤および前記ゲル緩衝液を含有する水溶液を、ガラスあるいは樹脂製の担持体に充填した後、重合開始剤および/または紫外線照射あるいは電離性放射線の照射により発生するラジカルによってゲル化させることにより製造する。重合開始剤としては、過硫酸アンモニウム(以下、APSと略す)等の過酸化物と、N,N,N’, N’テトラメチルエチレンジアミン(以下TEMEDと略す)等の還元剤を併用するレドックス型の重合開始剤が賞用されるが、これら特に限定されるものではない。上記過酸化物及び還元剤は全モノマーに対し、0.05〜5%(質量/容量)が使用される。また、重合温度は開始剤が機能する温度であれば特に限定されないが、通常15〜50℃の範囲が好ましい。 The precast gel of the present invention is prepared by filling a glass or resin carrier with an aqueous solution containing acrylamide, the compound (B), a crosslinking agent and the gel buffer, and then irradiating with a polymerization initiator and / or ultraviolet rays or ionizing. It is produced by gelling with radicals generated by irradiation with actinic radiation. As a polymerization initiator, a redox type that uses a peroxide such as ammonium persulfate (hereinafter abbreviated as APS) and a reducing agent such as N, N, N ′, N′tetramethylethylenediamine (hereinafter abbreviated as TEMED) in combination. A polymerization initiator is awarded, but is not particularly limited. The peroxide and reducing agent are used in an amount of 0.05 to 5% (mass / volume) based on the total monomers. The polymerization temperature is not particularly limited as long as it is a temperature at which the initiator functions, but is usually preferably in the range of 15 to 50 ° C.
本発明の電気泳動用プレキャストゲルは、トリス(ヒドロキシメチル)アミノメタン及び両性電解質を含有する泳動用緩衝液を使用して蛋白質のりん酸化状態に応じた分離をするために使用される。 The precast gel for electrophoresis of the present invention is used for separation according to the phosphorylation state of a protein using a buffer for electrophoresis containing tris (hydroxymethyl) aminomethane and an amphoteric electrolyte.
前記泳動緩衝液の組成は、トリス0.025mol/L、グリシン0.192mol/L、SDS0.1重量%である組成の泳動緩衝液を使用することが望ましい。この組成は、レムリーの泳動用緩衝液として、ゲル電気泳動法による蛋白質の分離に一般的に用いられるものである。 The composition of the electrophoresis buffer is preferably an electrophoresis buffer having a composition of Tris 0.025 mol / L, glycine 0.192 mol / L, and SDS 0.1% by weight. This composition is generally used for separation of proteins by gel electrophoresis as a buffer for running Lemmy.
あるいは、前記泳動緩衝液の組成は、トリス(ヒドロキシメチル)アミノメタン0.1mol/L、トリシン0.1mol/L、SDS0.1質量%である組成の泳動緩衝液を使用することが望ましい。この組成は、シャガーの泳動用緩衝液として、特にゲル電気泳動法による低分子量の蛋白質の分離に一般的に用いられるものである。 Alternatively, it is desirable to use an electrophoresis buffer having a composition of tris (hydroxymethyl) aminomethane 0.1 mol / L, tricine 0.1 mol / L, and SDS 0.1% by mass. This composition is generally used as a buffer for electrophoresis of a sugar, particularly for the separation of low molecular weight proteins by gel electrophoresis.
(実施例)
以下、実施例により本発明を説明するが、本発明はこれら実施例に限定されるものではない。
(Example)
EXAMPLES Hereinafter, although an Example demonstrates this invention, this invention is not limited to these Examples.
泳動用プレキャストゲルの作成方法
横幅12cm、縦10cmの長方形のガラス板と、上部に凹状の切り込みの入った同寸法のガラス板の間に、厚さ1mmのスペーサーとモノマー液が漏れないようにシリコンのシールを挟みガラスプレートを組み立てる。アクリルアミド濃度12%T、前記化合物(B)対アクリルアミド0.03質量%(遷移金属として亜鉛を使用)、N,N−メチレンビスアクリルアミド濃度3%C、並びに表−1に記載する実施例−1の組成のゲル緩衝液を含有するモノマー溶液に対し、APS0.002mol/LおよびTEMED0.006mol/Lとなるように添加混合後、プレート内に注入して25℃下で重合させ、電気泳動用ポリアクリルアミドゲルの分離層を得た。
Preparation of precast gel for electrophoresis Silicon seal to prevent leakage of 1 mm spacer and monomer liquid between a rectangular glass plate with a width of 12 cm and a length of 10 cm and a glass plate of the same size with a concave cut at the top Assemble the glass plate. Acrylamide concentration of 12% T, 0.03% by mass of the compound (B) with respect to acrylamide (using zinc as a transition metal), N, N-methylenebisacrylamide concentration of 3% C, and Example-1 described in Table-1 After adding and mixing to a monomer solution containing a gel buffer of the composition of APS 0.002 mol / L and TEMED 0.006 mol / L, the mixture was injected into a plate and polymerized at 25 ° C. A separation layer of acrylamide gel was obtained.
さらに、アクリルアミド濃度5%T、N,N−メチレンビスアクリルアミド濃度3%C、並びに表−1に記載する組成のゲル緩衝液を含有するモノマー溶液に対し、APS0.002mol/LおよびTEMED0.006mol/Lとなるように添加混合後、分離層の上に注入して25℃下で重合させ、電気泳動用ポリアクリルアミドゲルの濃縮層を得た。 Furthermore, for a monomer solution containing an acrylamide concentration of 5% T, an N, N-methylenebisacrylamide concentration of 3% C, and a gel buffer solution having the composition described in Table 1, APS 0.002 mol / L and TEMED 0.006 mol / After adding and mixing so as to be L, the mixture was poured onto the separation layer and polymerized at 25 ° C. to obtain a concentrated layer of polyacrylamide gel for electrophoresis.
泳動試験方法
トリス0.025mol/L、グリシン0.192mol/L、SDS0.1質量%のレムリー処方の泳動緩衝液を用いて電気泳動を実施した。蛋白質試料としてαカゼイン、脱りん酸化αカゼインを電気泳動した。脱りん酸化αカゼインは、αカゼイン溶解液にアルカリフォスファターゼ(ニッポンジーン製)を加えた後1晩静置して脱りん酸化処理した。
電気泳動は20mA定電流で行い、泳動末端が下から10mmの所で通電を中止した。
染色は、0.05質量%クマシーブリリアントブルー(以下、CBBと略す)G−250、12容量%酢酸、30容量%メタノール溶液中で振とう機を使用して60分間行い、脱色は12容量%酢酸、15容量%メタノール溶液中で振とう機を使用して120分間行った。
αカゼインおよび脱りん酸化αカゼインの移動度およびその差とそれぞれのバンドの鮮明さを表2−1に示す。
移動度とは蛋白質の移動距離をパーセントで表したものである。
(移動度%)=(ウェル下端から各バンドの位置までの距離)
/(ウェル下端から泳動末端までの距離)×100
Electrophoresis test method Electrophoresis was performed using an electrophoresis buffer of Remley formulation of Tris 0.025 mol / L, glycine 0.192 mol / L, and SDS 0.1% by mass. Α-casein and dephosphorylated α-casein were electrophoresed as protein samples. Dephosphorylated α-casein was dephosphorylated by adding alkaline phosphatase (manufactured by Nippon Gene) to the α-casein solution and allowing it to stand overnight.
Electrophoresis was performed at a constant current of 20 mA, and energization was stopped when the migration terminal was 10 mm from the bottom.
Staining was performed in a 0.05% by weight Coomassie brilliant blue (hereinafter abbreviated as CBB) G-250, 12% by volume acetic acid, 30% by volume methanol solution for 60 minutes, and decolorization was 12% by volume. The reaction was carried out in acetic acid and 15% by volume methanol solution for 120 minutes using a shaker.
Table 2-1 shows the mobility of α-casein and dephosphorylated α-casein and their differences and the sharpness of each band.
Mobility refers to the distance traveled by a protein in percent.
(Mobility%) = (Distance from bottom of well to each band position)
/ (Distance from bottom of well to end of migration) × 100
実施例−1と同様の方法で作成したプレキャストゲルを冷蔵下で8ヶ月間保管した後、実施例−1と同様の方法で泳動試験を行った。結果を表2−1の実施例−2に示す。 A precast gel prepared by the same method as in Example-1 was stored for 8 months under refrigeration, and then a migration test was performed in the same manner as in Example-1. The results are shown in Example-2 in Table 2-1.
表1の実施例−2のゲル緩衝液を用いてプレキャストゲルを作成した以外は実施例−1と同様に泳動試験を実施した。結果を表2−1の実施例−2に示す。 A migration test was performed in the same manner as in Example 1 except that a precast gel was prepared using the gel buffer of Example-2 in Table 1. The results are shown in Example-2 in Table 2-1.
アクリルアミド濃度7.5%Tに変更し、表1の実施例−3のゲル緩衝液を用いプレキャストゲルを作成した以外は実施例−1と同様に泳動試験を実施した。結果を表2−1の実施例−3に示す。 The migration test was carried out in the same manner as in Example 1 except that the pre-cast gel was prepared using the gel buffer of Example-3 in Table 1 with the acrylamide concentration changed to 7.5% T. The results are shown in Example 3 in Table 2-1.
表1の実施例−4のゲル緩衝液を用いた以外は実施例−1と同様の方法でプレキャストゲルを作成した。トリス0.1mol/L、トリシン0.1mol/L、SDS0.1質量%のシャガー処方の泳動緩衝液を用いて電気泳動を実施した。蛋白質試料および検出方法は実施例1と同様にした。結果を表2−1の実施例−4に示す。 A precast gel was prepared in the same manner as in Example-1 except that the gel buffer of Example-4 in Table 1 was used. Electrophoresis was performed using a running buffer of a Shagar formulation of Tris 0.1 mol / L, Tricine 0.1 mol / L, SDS 0.1 mass%. The protein sample and detection method were the same as in Example 1. The results are shown in Example 4 in Table 2-1.
(比較例1)
分離層にpH8.8の0.375mol/Lのトリス−塩酸ゲル緩衝液を、濃縮層にpH6.8の0.125mol/Lトリス−塩酸ゲル緩衝液を用いてプレキャストゲルを作成した以外は実施例−1と同様に泳動試験を実施した。結果を表2−2の比較例−1に示す。
(Comparative Example 1)
Implemented except that a precast gel was prepared using 0.375 mol / L Tris-HCl gel buffer solution at pH 8.8 for the separation layer and 0.125 mol / L Tris-HCl gel buffer solution at pH 6.8 for the concentration layer. The migration test was performed in the same manner as in Example-1. The results are shown in Comparative Example-1 in Table 2-2.
(比較例−2)
比較例−1と同様の方法で作成したプレキャストゲルを冷蔵下で6ヶ月間保管した後、実施例−1と同様の方法で泳動試験を行った。結果を表2−2の比較例−2に示す。
(Comparative Example-2)
A precast gel prepared in the same manner as in Comparative Example-1 was stored for 6 months under refrigeration, and then a migration test was performed in the same manner as in Example-1. The results are shown in Comparative Example-2 in Table 2-2.
(比較例−3)
分離層にpH6.8の0.375mol/Lのトリス−塩酸ゲル緩衝液を、濃縮層にpH6.8の0.125mol/Lトリス−塩酸ゲル緩衝液ゲル緩衝液を用いてプレキャストゲルを作成した以外は実施例−1と同様に泳動試験を実施した。結果を表2−2の比較例−3に示す。
(Comparative Example-3)
A precast gel was prepared using 0.375 mol / L Tris-hydrochloric acid gel buffer solution at pH 6.8 in the separation layer and 0.125 mol / L Tris-hydrochloric acid gel buffer gel buffer solution in the concentration layer at pH 6.8. Except for the above, the migration test was performed in the same manner as in Example-1. The results are shown in Comparative Example-3 in Table 2-2.
(比較例−4)
前記化合物(B)を加えなかった以外は実施例−1と同様にプレキャストゲルを作成し泳動試験を実施した。結果を表2−2の比較例−4に示す。
(Comparative Example-4)
A precast gel was prepared in the same manner as in Example 1 except that the compound (B) was not added, and a migration test was performed. The results are shown in Comparative Example-4 in Table 2-2.
(表1) ゲル緩衝液組成
MOPS:3−N−モルホリノプロパンスルホン酸
HEPES:N−2−ヒドロキシエチルピペラジン−N‘−2−エタンスルホン酸
(Table 1) Gel buffer composition
MOPS: 3-N-morpholinopropanesulfonic acid HEPES: N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid
(表2−1) 移動度(%)
(Table 2-1) Mobility (%)
(表2−2) 移動度(%)
(Table 2-2) Mobility (%)
表2−1に示すとおり実施例−1と3から5のプレキャストゲルでは、りん酸化αカゼインと脱りん酸化αカゼインはいずれも鮮明なバンドとなり明確な移動度差を得ることができ、本発明のプレキャストゲルはレムリーまたはシャガーの泳動用緩衝液を用いて蛋白質をそのりん酸化状態により分離することができた。 As shown in Table 2-1, in the precast gels of Examples-1 and 3 to 5, phosphorylated α-casein and dephosphorylated α-casein are both clear bands and a clear mobility difference can be obtained. The precast gel was able to separate proteins according to their phosphorylation state using Remley or Shagar's running buffer.
表2−1に示すとおり実施例−2から、本発明の電気泳動用プレキャストゲルは作成後6ヶ月経過しても、作成直後と同じバンド鮮明さ、移動度、りん酸化状態による移動度差を得ることができた。 As shown in Table 2-1, from Example-2, even when the precast gel for electrophoresis of the present invention has been produced for 6 months, the same band sharpness, mobility, and mobility difference due to phosphorylation state as those immediately after the production were obtained. I was able to get it.
表2−2に示すとおりレムリー処方のゲル緩衝液を用いた比較例−1と2のプレキャストゲルでは、作成直後は明確な移動度差を得ることができたが、りん酸化−脱りん酸化たんぱく質の移動度差は実施例−1に比べて小さく、また作成後6ヶ月経過後には、鮮明なバンドを得ることができなかった。 As shown in Table 2-2, in the precast gels of Comparative Examples-1 and 2 using the gel buffer of the Remley formulation, a clear mobility difference could be obtained immediately after the preparation, but phosphorylated-dephosphorylated protein. The difference in mobility was smaller than that of Example 1, and a clear band could not be obtained after 6 months from the preparation.
表2−2に示すとおり比較例−3のプレキャストゲルでは、明確な移動度差を得ることができなかった。バンドも不鮮明だった。 As shown in Table 2-2, in the precast gel of Comparative Example-3, a clear mobility difference could not be obtained. The band was also unclear.
表2−2に示すとおり比較例−4のプレキャストゲルでは、鮮明なバンドを得ることはできたが、αカゼインと脱りん酸化αカゼインの間に明確な移動度差を得ることができなかった。 As shown in Table 2-2, in the precast gel of Comparative Example-4, a clear band could be obtained, but a clear mobility difference could not be obtained between α-casein and dephosphorylated α-casein. .
以上の結果から、本発明の電気泳動用プレキャストゲルが、蛋白質のりん酸化状態を明確に分離することが可能であり、かつプレキャストゲルに必要とされる長期安定性を持つことは明らかである。 From the above results, it is clear that the precast gel for electrophoresis of the present invention can clearly separate the phosphorylated state of the protein and has the long-term stability required for the precast gel.
本発明の電気泳動用プレキャストゲルを用いることにより、蛋白質の分離能及びゲルの形状が長期安定で、分析方法が普及しているレムリーあるいはシャガーの泳動緩衝液が使用でき使用者が経済的かつ効率的に、蛋白質のりん酸化修飾状態の分析をすることが可能となり、産業上の利用可能性は甚だ大きい。
By using the precast gel for electrophoresis of the present invention, the separation ability of the protein and the shape of the gel are stable for a long period of time, and it is possible to use the Remley or Shagar electrophoresis buffer which is widely used for the analysis method. In particular, it is possible to analyze the phosphorylation modification state of a protein, and its industrial applicability is very large.
Claims (5)
(1)トリス(ヒドロキシメチル)アミノメタンおよび/またはビス(2−ヒドロキシエチル)イミノトリス(ヒドロキシメチル)メタンと1種以上の両性電解質として、グリシンおよび/またはトリシン、グリシンおよび/またはトリシン以外の両性電解質としてスレオニンを含有し、グリシンおよび/またはトリシン以外の両性電解質が、グリシンおよび/またはトリシンに対して63.2〜100mol%の範囲で含まれる両性電解質。
(2)pHが6.0〜6.8。
構造単位(A)
式中、M2+は遷移金属イオン It is an acrylamide copolymer aqueous gel having a structure represented by the following formula (A) in at least a part of the structure and containing a buffer solution having the following compositions (1) and (2). Precast gel for electrophoresis.
(1) Tris (hydroxymethyl) aminomethane and / or bis (2-hydroxyethyl) iminotris (hydroxymethyl) methane and one or more ampholytes as glycine and / or tricine, amphoteric electrolytes other than glycine and / or tricine An amphoteric electrolyte containing threonine as an amphoteric electrolyte other than glycine and / or tricine in an amount of 63.2 to 100 mol% based on glycine and / or tricine.
(2) pH is 6.0-6.8.
Structural unit (A)
In the formula, M 2+ is a transition metal ion.
化合物(B)
式中、M2+は遷移金属イオン Acrylamide, the following compound (B), a cross-linking agent, tris (hydroxymethyl) aminomethane and / or bis (2-hydroxyethyl) iminotris (hydroxymethyl) methane, and one or more ampholytes as glycine and / or tricine, Threonine is contained as an amphoteric electrolyte other than glycine and / or tricine, and the ampholyte other than glycine and / or tricine is comprised of an amphoteric electrolyte in a range of 63.2 to 100 mol% with respect to glycine and / or tricine , A method for producing a precast gel for electrophoresis, comprising polymerizing a mixture aqueous solution having a pH of 6.0 to 6.8.
Compound (B)
Where M2 + is a transition metal ion
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011275630A JP5967751B2 (en) | 2011-12-16 | 2011-12-16 | Precast gel for electrophoresis, production method and use thereof |
PCT/JP2012/081997 WO2013089076A1 (en) | 2011-12-16 | 2012-12-11 | Precast gel for electrophoresis, method for producing same, and method for using same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011275630A JP5967751B2 (en) | 2011-12-16 | 2011-12-16 | Precast gel for electrophoresis, production method and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013125014A JP2013125014A (en) | 2013-06-24 |
JP5967751B2 true JP5967751B2 (en) | 2016-08-10 |
Family
ID=48612523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011275630A Active JP5967751B2 (en) | 2011-12-16 | 2011-12-16 | Precast gel for electrophoresis, production method and use thereof |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP5967751B2 (en) |
WO (1) | WO2013089076A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6453326B2 (en) * | 2014-07-04 | 2019-01-23 | アトー株式会社 | Gel buffer for electrophoresis and polyacrylamide gel for electrophoresis |
WO2017066711A1 (en) * | 2015-10-14 | 2017-04-20 | Life Technologies Corporation | Electrophoresis gel with extended shelf life and high performance |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3942001B2 (en) * | 1999-12-02 | 2007-07-11 | ハイモ株式会社 | Polyacrylamide precast gel for electrophoresis, method for producing the same, and method for separating and analyzing proteins |
JP2002277438A (en) * | 2001-03-22 | 2002-09-25 | Hymo Corp | Electrophoretic gel, method of making thereof and application thereof |
AU2005335179B2 (en) * | 2005-08-01 | 2011-03-17 | Nard Institute, Ltd. | Polyacrylamide gel for electrophoresis, polyacrylamide gel electrophoresis method using the same, method of producing the same and acrylamide compound |
-
2011
- 2011-12-16 JP JP2011275630A patent/JP5967751B2/en active Active
-
2012
- 2012-12-11 WO PCT/JP2012/081997 patent/WO2013089076A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2013089076A1 (en) | 2013-06-20 |
JP2013125014A (en) | 2013-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6726821B1 (en) | Polyacrylamide precast gels for electrophoresis, process for producing the same and electroporesis method by using the gels | |
JP2588059B2 (en) | Method for producing polyacrylamide gel for electrophoresis | |
US11105769B2 (en) | System for rapid high-resolution gel electrophoresis | |
JP2013152246A (en) | Hydrolysis resistant polyacrylamide gel | |
JP3942001B2 (en) | Polyacrylamide precast gel for electrophoresis, method for producing the same, and method for separating and analyzing proteins | |
JP2002277438A (en) | Electrophoretic gel, method of making thereof and application thereof | |
JP5967751B2 (en) | Precast gel for electrophoresis, production method and use thereof | |
EP2183583B1 (en) | A buffer system for a long-lasting precast electrophoresis gel | |
US9448202B2 (en) | Electrophoresis buffer for extending the useful electrophoresis life of an electrophoresis gel | |
US20110308951A1 (en) | Long-lasting precast electrophoresis gel | |
AU2011245047B2 (en) | Electrophoresis buffer for faster migration, improved resolution and extended shelf-life | |
JP6846420B2 (en) | Electrophoretic gel with extended shelf life and high performance | |
JP2003004702A (en) | Method for manufacturing gel for high resolution electrophresis | |
WO2000067009A1 (en) | Mixed buffers in gel electrophoresis systems | |
KR0183040B1 (en) | Method of manufacturing polyacrylamide gel for electrophoresis | |
JP2021183956A (en) | Composition for gel, gel, and precast gel | |
JP2001242139A (en) | Electrophoresis method for dna | |
JP2014092450A (en) | Separation medium for electrophoresis | |
JP4838358B2 (en) | Precast gel for electrophoresis, method for producing the same, and method for using the same | |
JP2001242141A (en) | Electrophotresis method for dna |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20141114 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151106 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151207 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160324 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160407 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160701 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160701 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5967751 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |